Volgen
Marc Lobbes
Marc Lobbes
Assistant professor Radiology
Geverifieerd e-mailadres voor mumc.nl
Titel
Geciteerd door
Geciteerd door
Jaar
Supplemental MRI screening for women with extremely dense breast tissue
MF Bakker, SV de Lange, RM Pijnappel, RM Mann, PHM Peeters, ...
New England Journal of Medicine 381 (22), 2091-2102, 2019
4772019
Breast implants and the risk of anaplastic large-cell lymphoma in the breast
M de Boer, FE van Leeuwen, M Hauptmann, LIH Overbeek, JP de Boer, ...
JAMA oncology 4 (3), 335-341, 2018
3012018
Breast implants and the risk of anaplastic large-cell lymphoma in the breast
M de Boer, FE van Leeuwen, M Hauptmann, LIH Overbeek, JP de Boer, ...
JAMA oncology 4 (3), 335-341, 2018
3012018
The role of magnetic resonance imaging in assessing residual disease and pathologic complete response in breast cancer patients receiving neoadjuvant chemotherapy: a systematic …
MBI Lobbes, R Prevos, M Smidt, VCG Tjan-Heijnen, M Van Goethem, ...
Insights into imaging 4, 163-175, 2013
2192013
Contrast-enhanced spectral mammography in patients referred from the breast cancer screening programme
MBI Lobbes, U Lalji, J Houwers, EC Nijssen, PJ Nelemans, ...
European radiology 24, 1668-1676, 2014
2162014
Contrast-enhanced mammography: state of the art
MS Jochelson, MBI Lobbes
Radiology 299 (1), 36-48, 2021
1702021
Evaluation of low-energy contrast-enhanced spectral mammography images by comparing them to full-field digital mammography using EUREF image quality criteria
UC Lalji, C Jeukens, I Houben, PJ Nelemans, RE van Engen, ...
European radiology 25, 2813-2820, 2015
1482015
Contrast enhanced mammography: techniques, current results, and potential indications
MBI Lobbes, ML Smidt, J Houwers, VC Tjan-Heijnen, JE Wildberger
Clinical radiology 68 (9), 935-944, 2013
1482013
MRI versus mammography for breast cancer screening in women with familial risk (FaMRIsc): a multicentre, randomised, controlled trial
S Saadatmand, HA Geuzinge, EJT Rutgers, RM Mann, ...
The Lancet Oncology 20 (8), 1136-1147, 2019
1462019
Contrast enhanced spectral mammography: a review
BK Patel, MBI Lobbes, J Lewin
Seminars in Ultrasound, CT and MRI 39 (1), 70-79, 2018
1372018
Contrast-enhanced spectral mammography in recalls from the Dutch breast cancer screening program: validation of results in a large multireader, multicase study
UC Lalji, IPL Houben, R Prevos, S Gommers, M van Goethem, ...
European radiology 26, 4371-4379, 2016
1322016
The quality of tumor size assessment by contrast-enhanced spectral mammography and the benefit of additional breast MRI
MBI Lobbes, UC Lalji, PJ Nelemans, I Houben, ML Smidt, E Heuts, ...
Journal of Cancer 6 (2), 144, 2015
1282015
MR imaging as an additional screening modality for the detection of breast cancer in women aged 50–75 years with extremely dense breasts: the DENSE trial study design
MJ Emaus, MF Bakker, PHM Peeters, CE Loo, RM Mann, MDF De Jong, ...
Radiology 277 (2), 527-537, 2015
1212015
Image-guided breast biopsy and localisation: recommendations for information to women and referring physicians by the European Society of Breast Imaging
U Bick, RM Trimboli, A Athanasiou, C Balleyguier, PAT Baltzer, ...
Insights into imaging 11, 1-18, 2020
1182020
The role of MRI in axillary lymph node imaging in breast cancer patients: a systematic review
VJL Kuijs, M Moossdorff, RJ Schipper, RGH Beets-Tan, EM Heuts, ...
Insights into imaging 6 (2), 203-215, 2015
1142015
A novel less-invasive approach for axillary staging after neoadjuvant chemotherapy in patients with axillary node-positive breast cancer by combining radioactive iodine seed …
TJA van Nijnatten, JM Simons, ML Smidt, CC van der Pol, PJ van Diest, ...
Clinical breast cancer 17 (5), 399-402, 2017
1122017
Clinically node negative breast cancer patients undergoing breast conserving therapy, sentinel lymph node procedure versus follow-up: a Dutch randomized controlled multicentre …
LM Van Roozendaal, MLG Vane, T Van Dalen, JA van der Hage, ...
BMC cancer 17 (1), 1-8, 2017
1102017
Radiation exposure of contrast-enhanced spectral mammography compared with full-field digital mammography
CR Jeukens, UC Lalji, E Meijer, B Bakija, R Theunissen, JE Wildberger, ...
Investigative radiology 49 (10), 659-665, 2014
1102014
Is there more than C-reactive protein and fibrinogen?: The prognostic value of soluble CD40 ligand, interleukin-6 and oxidized low-density lipoprotein with respect to coronary …
MBI Lobbes, E Lutgens, S Heeneman, K Cleutjens, ME Kooi, ...
Atherosclerosis 187 (1), 18-25, 2006
1062006
Clinical tumor stage is the most important predictor of pathological complete response rate after neoadjuvant chemotherapy in breast cancer patients
B Goorts, TJA van Nijnatten, L de Munck, M Moossdorff, EM Heuts, ...
Breast cancer research and treatment 163, 83-91, 2017
1042017
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20